Загрузка...
HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
BACKGROUND: Epidermal growth factor receptor (EGFR) has emerged as an important therapeutic target. Overexpression of EGFR is frequently observed in hepatocellular carcinoma (HCC) and EGFR activation has been proven to be a potential determinant of primary resistance of HCC cells to sorafenib. In ou...
Сохранить в:
| Опубликовано в: : | Cell Biosci |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7076995/ https://ncbi.nlm.nih.gov/pubmed/32190291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00407-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|